Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies.
Valentina Vignali appointed as Investment Associate
Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital.
Timo Koopmans appointed as new Investment Manager of Utrecht Health Seed Fund
The Utrecht Health Seed Fund is happy to announce the start of its new Investment Manager: Timo Koopmans. Timo holds a PhD in medicinal chemistry from Utrecht University and as a startup founder himself, understands the challenges young companies face.
Moveshelf raises €1.7M to accelerate growth and international sales of its Information System for Movement Disorders
Moveshelf is a private digital health company which supplies a novel information system for movement and musculoskeletal disorders.
Utrecht Health Seed Fund’s first anniversary!
Before we knew, we’re celebrating Utrecht Health Seed Fund’s first anniversary!
